在盘子中建立功能视网膜:诱导多能干细胞基视网膜神经元差异化的进展和前景
Nonthaphat Kent Wong1,2, Shea Ping Yip1,2, Chien-Ling Huang1,2
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
International journal of molecular sciences
|September 9, 2023
概括
诱导多能干细胞 (iPSC) 通过产生视网膜细胞,为治疗视网膜退行性疾病提供了一个有希望的途径. 这种方法有助于理解视网膜发生和开发有效的视力丧失细胞疗法.
科学领域:
- 眼科医生 眼科 眼科
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 视网膜退行性疾病,如RP,玻璃眼和AMD导致显著的视力损失.
- 目前针对这些疾病的治疗方法不足.
- 动物模型对人类的相关性有限,并且很难获得人类组织.
研究的目的:
- 审查区分视网膜神经元与诱导多能干细胞 (iPSCs) 的协议.
- 突出使用iPSC来研究人类视网膜生成和疾病机制.
- 强调验证分化的视网膜细胞的重要性.
主要方法:
- 使用诱导多能干细胞 (iPSCs) 来产生视网膜细胞群.
- 采用干细胞技术生产视网膜质细胞 (RGC) 和光受体.
- 开发视网膜有机体作为体外模型用于疾病研究和差异化分析.
主要成果:
- iPSCs促进各种视网膜细胞类型的产生.
- 视网膜有机体是研究差异化和疾病的宝贵工具.
- 已建立的协议允许产生特定的视网膜神经元群体.
结论:
- 基于干细胞的方法,特别是使用iPSC,对于推进视网膜研究和治疗至关重要.
- 来自iPSC的视网膜细胞和有机体为了解视网膜疾病提供了强大的平台.
- 进一步的研究和验证对于这些细胞疗法的临床转化至关重要.
相关概念视频
Induced Pluripotent Stem Cells
24.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


